Genomics and Proteomic Tools for Emerging Markets in Asia-Pacific

Report Highlights

The Asia-Pacific genomics and proteomics tools market should reach $5.9 billion by 2023 from $4.0 billion in 2019 at a compound annual growth rate (CAGR) of 10.4% for the forecast period of 2019 to 2023.

Report Includes

• 22 data tables and 20 additional tables
• An overview of the Asia-Pacific (APAC) markets for genomics and proteomic tools within the life sciences industry
• Country-specific data and market analysis of genomics and proteomic technologies for China, India, South Korea and other emerging economies
• Analyses of the APAC market trends, with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2023
• Information on factors driving the industry’s growth, current trends and opportunities, regulatory challenges and technological advancements that will shape the future marketplace within APAC region
• Identification of the companies best-positioned to meet the enormous supply demand equation because of their proprietary technologies, strategic alliances or other advantages
• Assessment of the competitive landscape and data corresponding to shares of leading market participants
• Patent study and analysis covering significant allotments of the U.S. patents
• Company profiles of leading market players within the APAC emerging markets, including 3Billion Inc., Bio-Rad Laboratories Inc., GE Healthcare, Novogene Corp., Qiagen NV, Thermo Fisher Scientific Inc., and Waters Corp.

Report Scope

The report would cover the Genomics and Proteomics Tools market, dynamics and competitive landscape of the Emerging markets in the Asia-Pacific. Key countries to be covered includes-China, South Korea and India. The market would cover products or tools for performing genomics and proteomics studies. Technologies and the products that would be covered in the report include- Sequencing technologies-Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, Nucleic Acid Sample Preparation technologies(technique) and Separation Technologies for Nucleic Acids. A competitive Landscape for key selected technologies is covered along with profiles of manufacturers engaged in providing related technological products or services.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Heat Pumps: Global Markets to 2030 (MFG090B)
• G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets (BIO136B)
• Global Markets for Laser Systems, Components and Materials (PHO002D)
• Liver Disease Treatments: The Global Market (PHM057D)
• Global Fuel Cell Stack Market (FCB070A)